Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Jameson

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Thyroid : Official Journal of the American Thyroid Association|January 1, 1994
Mechanisms by which thyroid hormone receptor mutations cause clinical syndromes of resistance to thyroid hormoneJ L Jameson
The Journal of Clinical Endocrinology and Metabolism|April 1, 1992
Thyroid hormone resistance: pathophysiology at the molecular levelJ L Jameson
Endocrine Reviews|August 24, 1999
Citation for the 1999 Robert H. Williams Distinguished Leadership Award of the Endocrine Society to Dr. Joel F. HabenerJ L Jameson
Molecular and Cellular Endocrinology|December 20, 1996
Inherited disorders of the gonadotropin hormonesJ L Jameson
Molecular Endocrinology (Baltimore, Md.)|November 7, 1999
AP-2 (activating protein 2) and Sp1 (selective promoter factor 1) regulatory elements play distinct roles in the control of basal activity and cyclic adenosine 3',5'-monophosphate responsiveness of the human chorionic gonadotropin-beta promoterW Johnson, J L Jameson
The Journal of Biological Chemistry|July 25, 1993
Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistanceT Nagaya, J L Jameson
The Journal of Biological Chemistry|November 15, 1993
Distinct dimerization domains provide antagonist pathways for thyroid hormone receptor actionT Nagaya, J L Jameson
Endocrinology|February 4, 1998
Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormoneT Tagami, J L Jameson
Molecular and Cellular Endocrinology|August 15, 2000
Role of Ets2 in cyclic AMP regulation of the human chorionic gonadotropin beta promoterW Johnson, J L Jameson
The Journal of Clinical Endocrinology and Metabolism|February 1, 1990
Clinical review 5: Recombinant DNA strategies for determining the molecular basis of endocrine disordersJ L Jameson, A Arnold
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Thyroid : Official Journal of the American Thyroid Association|January 1, 1994
Mechanisms by which thyroid hormone receptor mutations cause clinical syndromes of resistance to thyroid hormoneJ L Jameson
The Journal of Clinical Endocrinology and Metabolism|April 1, 1992
Thyroid hormone resistance: pathophysiology at the molecular levelJ L Jameson
Endocrine Reviews|August 24, 1999
Citation for the 1999 Robert H. Williams Distinguished Leadership Award of the Endocrine Society to Dr. Joel F. HabenerJ L Jameson
Molecular and Cellular Endocrinology|December 20, 1996
Inherited disorders of the gonadotropin hormonesJ L Jameson
Molecular Endocrinology (Baltimore, Md.)|November 7, 1999
AP-2 (activating protein 2) and Sp1 (selective promoter factor 1) regulatory elements play distinct roles in the control of basal activity and cyclic adenosine 3',5'-monophosphate responsiveness of the human chorionic gonadotropin-beta promoterW Johnson, J L Jameson
The Journal of Biological Chemistry|July 25, 1993
Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistanceT Nagaya, J L Jameson
The Journal of Biological Chemistry|November 15, 1993
Distinct dimerization domains provide antagonist pathways for thyroid hormone receptor actionT Nagaya, J L Jameson
Endocrinology|February 4, 1998
Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormoneT Tagami, J L Jameson
Molecular and Cellular Endocrinology|August 15, 2000
Role of Ets2 in cyclic AMP regulation of the human chorionic gonadotropin beta promoterW Johnson, J L Jameson
The Journal of Clinical Endocrinology and Metabolism|February 1, 1990
Clinical review 5: Recombinant DNA strategies for determining the molecular basis of endocrine disordersJ L Jameson, A Arnold
Pageof 18